Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

24 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Predictive value of clinical and radiomic features for radiation therapy response in patients with lymph node-positive head and neck cancer.
Franzese C, Lillo S, Cozzi L, Teriaca MA, Badalamenti M, Di Cristina L, Vernier V, Stefanini S, Dei D, Pergolizzi S, De Virgilio A, Mercante G, Spriano G, Mancosu P, Tomatis S, Scorsetti M. Franzese C, et al. Among authors: teriaca ma. Head Neck. 2023 May;45(5):1184-1193. doi: 10.1002/hed.27332. Epub 2023 Feb 23. Head Neck. 2023. PMID: 36815619
Stereotactic body radiation therapy (SBRT) on renal cell carcinoma, an overview of technical aspects, biological rationale and current literature.
Francolini G, Detti B, Ingrosso G, Desideri I, Becherini C, Carta G, Pezzulla D, Caramia G, Dominici L, Maragna V, Teriaca MA, Bottero M, Livi L. Francolini G, et al. Among authors: teriaca ma. Crit Rev Oncol Hematol. 2018 Nov;131:24-29. doi: 10.1016/j.critrevonc.2018.08.010. Epub 2018 Aug 28. Crit Rev Oncol Hematol. 2018. PMID: 30293702 Review.
Efficacy and Tolerability of CyberKnife Stereotactic Robotic Radiotherapy for Primary or Secondary Orbital Lesions: A Single-Center Retrospective Experience.
Desideri I, Francolini G, Carta GA, Di Cataldo V, Masi L, Meattini I, Bonomo P, Loi M, Greto D, Visani L, Lo Russo M, Grassi R, Teriaca MA, Garlatti P, Nardi C, Livi L. Desideri I, et al. Among authors: teriaca ma. Technol Cancer Res Treat. 2019 Jan 1;18:1533033818818561. doi: 10.1177/1533033818818561. Technol Cancer Res Treat. 2019. PMID: 30803353 Free PMC article. Clinical Trial.
Regorafenib in glioblastoma recurrence: A case report.
Detti B, Scoccianti S, Lucidi S, Maragna V, Teriaca MA, Ganovelli M, Desideri I, Lorenzetti V, Scoccimarro E, Greto D, Livi L. Detti B, et al. Among authors: teriaca ma. Cancer Treat Res Commun. 2021;26:100263. doi: 10.1016/j.ctarc.2020.100263. Epub 2020 Dec 10. Cancer Treat Res Commun. 2021. PMID: 33338858 Free article.
The impact of stereotactic ablative radiotherapy on oligoprogressive metastases from renal cell carcinoma.
Franzese C, Marini B, Baldaccini D, Badalamenti M, Navarria P, Bellu L, Franceschini D, Comito T, Clerici E, Teriaca MA, Massaro M, Di Cristina L, Lo Faro L, Tomatis S, Scorsetti M. Franzese C, et al. Among authors: teriaca ma. J Cancer Res Clin Oncol. 2023 Jul;149(8):4411-4417. doi: 10.1007/s00432-022-04352-z. Epub 2022 Sep 15. J Cancer Res Clin Oncol. 2023. PMID: 36109401
Stereotactic Radiotherapy after Incomplete Transarterial (Chemo-) Embolization (TAE\TACE) versus Exclusive TAE or TACE for Treatment of Inoperable HCC: A Phase III Trial (NCT02323360).
Comito T, Loi M, Franzese C, Clerici E, Franceschini D, Badalamenti M, Teriaca MA, Rimassa L, Pedicini V, Poretti D, Solbiati LA, Torzilli G, Ceriani R, Lleo A, Aghemo A, Santoro A, Scorsetti M. Comito T, et al. Among authors: teriaca ma. Curr Oncol. 2022 Nov 16;29(11):8802-8813. doi: 10.3390/curroncol29110692. Curr Oncol. 2022. PMID: 36421345 Free PMC article. Clinical Trial.
24 results